Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Geoffrey P. Lomax"'
Regulated, reliable, and reputable: Protect patients with uniform standards for stem cell treatments
Publikováno v:
Stem Cells Translational Medicine, Vol 9, Iss 5, Pp 547-553 (2020)
Abstract The promise of cell and gene therapies is being realized as new products emerge to treat diseases once considered intractable. These treatments are emerging amidst reports of patients being injured by unproven “stem cell” interventions.
Externí odkaz:
https://doaj.org/article/938502015cfa44eabc10b6895bd38f45
Autor:
Andreas Kurtz, Stefanie Seltmann, Amos Bairoch, Marie-Sophie Bittner, Kevin Bruce, Amanda Capes-Davis, Laura Clarke, Jeremy M. Crook, Laurence Daheron, Johannes Dewender, Adam Faulconbridge, Wataru Fujibuchi, Alexander Gutteridge, Derek J. Hei, Yong-Ou Kim, Jung-Hyun Kim, Anja Kolb- Kokocinski, Fritz Lekschas, Geoffrey P. Lomax, Jeanne F. Loring, Tenneille Ludwig, Nancy Mah, Tohru Matsui, Robert Müller, Helen Parkinson, Michael Sheldon, Kelly Smith, Harald Stachelscheid, Glyn Stacey, Ian Streeter, Anna Veiga, Ren-He Xu
Publikováno v:
Stem Cell Reports, Vol 10, Iss 1, Pp 1-6 (2018)
Unambiguous cell line authentication is essential to avoid loss of association between data and cells. The risk for loss of references increases with the rapidity that new human pluripotent stem cell (hPSC) lines are generated, exchanged, and impleme
Externí odkaz:
https://doaj.org/article/41d7834985bb42c5878caa009fac3aaa
Autor:
K.I. Agladze, Ibrahim Akin, Michail A. Alterman, Abdolreza Ardeshirylajimi, Alessia Bertero, Rahulkumar Bhoi, Natacha Breuls, Anne Bush, Francesca Caloni, Ivan Carcamo-Orive, Zhifen Chen, Teresa Coccini, Massimo Conese, Chad A. Cowan, Nathan James Cunningham, Ibrahim El-Battrawy, Benjamin S. Freedman, Andrée Gauthier-Fisher, Melkamu Getie-Kebtie, Nefele Giarratana, Madelyn A. Gillentine, Christopher Grunseich, Mirabelle S.H. Ho, Miriel S.H. Ho, Deborah A. Hursh, Gentaro Ikeda, Ji Hye Jung, Martin H. Kang, Yong Kyun Kim, Jacqueline Kowitz, Siegfried Lang, Onofrio Laselva, Jennifer Lei, Sandra L. Leibel, Clifford L. Librach, Geoffrey P. Lomax, Maryam Mahmoodinia Maymand, Rachael N. McVicar, Andrew R. Mendelsohn, Anna R. Mendelsohn, Sadegh lotfalah Moradi, Yasuhiro Murakawa, Dan Nir, Connor G. O'Brien, A.D. Podgurskaya, Natalia S. Pripuzova, Maurilio Sampaolesi, M.M. Slotvitsky, Evan Y. Snyder, Shi Su, Colin Sweeney, Bernard Thébaud, V.A. Tsvelaya, Haritha Vallabhaneni, Evgeniya A. Vaskova, Huaxiao Yang, Phillip C. Yang, Laura Yedigaryan, Masahito Yoshihara, Xiaobo Zhou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d308ba69a79386fc00d6f4eab904758
https://doi.org/10.1016/b978-0-323-99892-5.01002-1
https://doi.org/10.1016/b978-0-323-99892-5.01002-1
Autor:
Ian Streeter, Stefanie Seltmann, Anja Kolb Kokocinski, Geoffrey P. Lomax, Jeanne F. Loring, Glyn Stacey, Harald Stachelscheid, Laurence Daheron, Kelly P. Smith, Tohru Matsui, K. Bruce, Adam Faulconbridge, Wataru Fujibuchi, Michael Sheldon, Robert Müller, Jung-Hyun Kim, Marie-Sophie Bittner, Derek J. Hei, Johannes Dewender, Laura Clarke, Yong-Ou Kim, Anna Veiga, Amos Marc Bairoch, Andreas Kurtz, Amanda Capes-Davis, Helen Parkinson, Fritz Lekschas, Tenneille Ludwig, Jeremy M. Crook, Ren-He Xu, Nancy Mah, Alexander Gutteridge
Publikováno v:
Stem Cell Reports, Vol 10, Iss 1, Pp 1-6 (2018)
Stem Cell Reports
Stem Cell Reports, Vol. 10, No 1 (2018) pp. 1-6
Stem Cell Reports
Stem Cell Reports, Vol. 10, No 1 (2018) pp. 1-6
Unambiguous cell line authentication is essential to avoid loss of association between data and cells. The risk for loss of references increases with the rapidity that new human pluripotent stem cell (hPSC) lines are generated, exchanged, and impleme
Autor:
John A. Zaia, Jason Tabor, Rodica Stan, Mary Perrin, Virginia Le Verche, Shirley Johnson, Teresa Kim, Geoffrey P. Lomax, Pamela Giesie
Publikováno v:
Stem Cells Translational Medicine
Summary The California Institute for Regenerative Medicine has formed a group of clinics called the Alpha Stem Cell Clinics Network. Its goal is to accelerate clinical trials of stem cell-based therapies for diseases with unmet medical needs. In this
Publikováno v:
Stem Cells Translational Medicine. 4:123-129
Summary Human somatic cell reprogramming is a leading technology for accelerating disease modeling and drug discovery. The Deriving Induced Stem Cells Using Stored Specimens (DISCUSS) project is a consensus-building initiative designed to consider ho
Autor:
Kalina Kamenova, Michael McDonald, Lori Knowles, Jay M. Baltz, Gregory S. Korbutt, Zubin Master, Shelly Benjaminy, James V. Lavery, Paul A. Cassar, Timothy Caulfield, Marianne Clark, Geoffrey P. Lomax, Nina Preto, Rosario Isasi, Ubaka Ogbogu, Bartha Maria Knoppers, Maeghan Toews, Amy Zarzeczny
Publikováno v:
EMBO reports. 16:2-6
Few areas of scientific inquiry have received the amount of attention from politicians, the media and the ethics community that research involving human stem cells has received. A large part of this attention, particularly in the early days of the fi
Autor:
Andreas Kurtz, Martin F. Pera, Tsuneo Takahashi, Nafees Rahman, Ruttachuk Rungsiwiwut, Michael Sheldon, Qi Zhou, Jung-Hyun Kim, Jeremy M. Crook, Thomas Novak, Laura Clarke, Geoffrey P. Lomax, Steve Oh, Tohru Masui, Jeanne F. Loring, Orla O'Shea, Fanyi Zeng, Wataru Fujibuchi, Tenneille Ludwig, Maneesha S. Inamdar, Shin Kawamata, Meri T. Firpo, Patricia Pranke, Rosario Isasi, Bao-Zhu Yuan, Ji-Hyeon Ju, Glyn Stacey, Soo Kyung Koo
Publikováno v:
STEM CELLS Translational Medicine
Stem Cells Translational Medicine
Stem Cells Translational Medicine
This article summarizes the recent activity of the International Stem Cell Banking Initiative (ISCBI) held at the California Institute for Regenerative Medicine (CIRM) in California (June 26, 2016) and the Korean National Institutes for Health in Kor
Publikováno v:
Stem Cells Translational Medicine. 3:979-991
In March 2013, the California Institute for Regenerative Medicine, in collaboration with the NIH Center for Regenerative Medicine, held a 2-day workshop on cell therapies for Parkinson's disease (PD), with the goals of reviewing the state of stem cel